Clinical trial
Dose-finding Study Using Pentostatin for Injection in the Treatment of…
NCT00032773 · Astex Pharmaceuticals, Inc., Industry · Terminated
Key facts
| NCT number | NCT00032773 |
|---|---|
| Title | Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD |
| Official title | A Sequentially Adaptive, Open Label, Dose-finding, Phase I/II Trial of Pentostatin in the Treatment of Steroid-refractory Acute Graft Versus Host Disease (aGvHD) |
| Lead sponsor | Astex Pharmaceuticals, Inc., Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Acute Graft Versus Host Disease |
| Intervention type | Drug |
| Interventions | pentostatin for injection |
| Enrollment | 36 |
| Start date | Jan 30, 2002 |
| Primary completion | Nov 3, 2005 |
| Completion | Nov 3, 2005 |
| First posted | Apr 4, 2002 |
| Last update posted | Aug 2, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: